Effect of anti-glycosphingolipid monoclonal antibodies in pathogenic fungal growth and differentiation. Characterization of monoclonal antibody MEST-3 directed to Manpα1→3Manpα1→2IPC

BMC Microbiology

Volumn 10, Issue , 2010, Pages

  Toledo, Marcos S ^a   Tagliari, Loriane ^a   Suzuki, Erika ^a   Silva, Claudinei M ^a   Straus, Anita H ^a   Takahashi, Helio K ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; ANTIGEN; BETA DEXTRO GALACTOFURANOSE; GLUCOSYLCERAMIDE; GLYCOINOSITOL PHOSPHORYLCERAMIDE DERIVATIVE; GLYCOLIPID; GLYCOLIPID ANTIGEN PB 2; IMMUNOGLOBULIN G2A ANTIBODY; MANNOSE; MEST 1 ANTIBODY; MEST 2 ANTIBODY; MEST 3 ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; FUNGUS ANTIBODY; FUNGUS ANTIGEN; GLYCOSPHINGOLIPID; IMMUNOGLOBULIN G;

ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; COLONY FORMATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG EFFECT; FUNGUS CULTURE; FUNGUS GROWTH; HISTOPLASMA CAPSULATUM; NONHUMAN; PARACOCCIDIOIDES BRASILIENSIS; SPOROTHRIX SCHENCKII; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; FUNGUS; GROWTH, DEVELOPMENT AND AGING; HISTOPLASMA; IMMUNOLOGY; METABOLISM; MICROBIOLOGICAL PHENOMENA AND FUNCTIONS; MYCELIUM; PARACOCCIDIOIDES; PHYSIOLOGY; SPOROTHRIX;

AJELLOMYCES CAPSULATUS; FUNGI; PARACOCCIDIOIDES BRASILIENSIS; SPOROTHRIX SCHENCKII;

ANTIBODIES, FUNGAL; ANTIBODIES, MONOCLONAL; ANTIGENS, FUNGAL; CELL PROLIFERATION; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FUNGI; GLYCOSPHINGOLIPIDS; HISTOPLASMA; IMMUNOGLOBULIN G; MICROBIOLOGICAL PROCESSES; MYCELIUM; PARACOCCIDIOIDES; SPOROTHRIX;

EID: 77749330720     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-10-47     Document Type: Article

References (41)

1. Historical introduction. E Drouhet, Medical Mycology Arnold New York, Ajello L, Hay R, 1998 3 42
2. Currently Used Antimycotics: Spectrum, Mode of Action and Resistance Occurrence. IEJA François AM Aerts BPA Cammue K Thevissen, Current Drug Targets 2005 6 895 907 10.2174/138945005774912744 16375673
3. Biological properties of aureobasidin A, a cyclic depsipeptide antifungal antibiotic. K Takesako H Kuroda T Inoue F Haruna Y Yoshikawa I Kato K Uchida T Hiratani H Yamaguchi, J Antibiot 1993 46 1414 1420 8226319 (Pubitemid 23290990)
4. Antifungals targeted to sphingolipid synthesis: focus on inositol phosphorylceramide synthase. NH Georgopapadakou, Expert Opin Investig Drugs 2000 9 1787 1796 10.1517/13543784.9.8.1787 11060777
5. Sphingolipid synthesis as a target for antifungal drugs. Complementation of the inositol phosphorylceramide synthase defect in a mutant strain of Saccharomyces cerevisiae by the AUR1 gene. MM Nagiec EE Nagiec JA Baltisberger GB Wells RL Lester RC Dickson, J Biol Chem 1997 272 9809 9817 10.1074/jbc.272.15.9809 9092515
6. Trypanosomatid and fungal glycolipids and sphingolipids as infectivity factors and potential targets for development of new therapeutic strategies. E Suzuki AK Tanaka MS Toledo SB Levery HK Takahashi AH Straus, Biochim Biophys Acta 2008 1780 362 369 17976917
7. Current relevance of fungal and trypanosomatid glycolipids and sphingolipids: studies defining structures conspicuously absent in mammals. HK Takahashi MS Toledo E Suzuki L Tagliari AH Straus, An Acad Bras Cienc 2009 81 477 488 19722017
8. Occurrence of novel antigenic phosphoinositol-containing sphingolipids in the pathogenic yeast Histoplasma capsulatum. K Barr RL Lester, Biochemistry 1984 23 5581 5588 10.1021/bi00318a031 6509037
9. Carbohydrate structures of three novel phosphoinositol-containing sphingolipids from the yeast Histoplasma capsulatum. K Barr RA Laine RL Lester, Biochemistry 1984 23 5589 5596 10.1021/bi00318a032 6509038
10. Glycolipids from Paracoccidioides brasiliensis. Isolation of a galactofuranose-containing glycolipid reactive with sera of patients with paracoccidioidomycosis. MS Toledo E Suzuki AH Straus HK Takahashi, J Med Vet Mycol 1995 33 247 251 10.1080/02681219580000501 8531023
11. Structure elucidation of sphingolipids from the mycopathogen Paracoccidioides brasiliensis : An immunodominant -galactofuranose residue is carried by a novel glycosylinositol phosphorylceramide antigen. SB Levery MS Toledo AH Straus HK Takahashi, Biochemistry 1998 37 8764 8775 10.1021/bi9730083 9628738
12. Immunochemical characterization of carbohydrate antigens from fungi, protozoa and mammals by monoclonal antibodies directed to glycan epitopes. AH Straus E Suzuki MS Toledo C Takizawa HK Takahashi, Braz J Med Biol Res 1995 28 919 923 8555996
13. A monoclonal antibody directed to terminal residue of beta-galactofuranose of a glycolipid antigen isolated from Paracoccidioides brasiliensis : cross-reactivity with Leishmania major and Trypanosoma cruzi. E Suzuki MS Toledo HK Takahashi AH Straus, Glycobiology 1997 7 463 468 10.1093/glycob/7.4.463 9184826
14. Expression of antibodies directed to Paracoccidioides brasiliensis glycosphingolipids during the course of paracoccidioidomycosis treatment. S Bertini AL Colombo HK Takahashi AH Straus, Clin Vaccine Immunol 2007 14 150 156 10.1128/CVI.00285-06 17135452
15. Analysis of glycosylinositol phosphorylceramides expressed by the opportunistic mycopathogen Aspergillus fumigatus. MS Toledo SB Levery B Bennion LL Guimares SA Castle R Lindsey M Momany C Park AH Straus HK Takahashi, J Lipid Res 2007 48 1801 1824 10.1194/jlr.M700149-JLR200 17488996
16. Structural elucidation of novel phosphocholine-containing glycosylinositol-phosphoceramide in filamentous fungi and their induction of cell death of cultured rice cells. K Aoki R Uchiyama S Itonori S Sugita FS Che A Isogai N Hada T Takeda H Kumagai K Yamamoto, Biochem J 2004 378 461 472 10.1042/BJ20031307 14583095
17. Glycosphingolipids of the model fungus Aspergillus nidulans : characterization of GIPCs with oligo-alpha-mannose-type glycans. B Bennion C Park M Fuller R Lindsey M Momany R Jennemann SB Levery, J Lipid Res 2003 44 2073 2088 10.1194/jlr.M300184-JLR200 12923229
18. Molecular analysis of a novel family of complex glycoinositolphosphoryl ceramides from Cryptococcus neoformans : Structural differences between encapsulated and acapsular yeast forms. N Heise ALS Gutierrez KA Mattos C Jones R Wait JO Previato L Mendonça-Previato, Glycobiology 2002 12 409 420 10.1093/glycob/cwf053 12122022
19. Glycosylinositolphosphoceramides in Aspergillus fumigatus. C Simenel B Coddeville M Delepierre JP Latgé T Fontaine, Glycobiology 2008 18 84 96 10.1093/glycob/cwm122 17971386
20. Isolation and composition of inositolphosphorylceramide-type sphingolipids of hyphal forms of Candida albicans. GB Wells RC Dickson RL Lester, J Bacteriol 1996 178 6223 6226 8892822
21. 3-unsaturation in cerebrosides of Paracoccidioides brasiliensis and Aspergillus fumigatus. MS Toledo SB Levery AH Straus E Suzuki M Momany J Glushka JM Moulton HK Takahashi, Biochemistry 1999 38 7294 7306 10.1021/bi982898z 10353841
22. Structure elucidation of sphingolipids from the Sporothrix schenckii: Identification of novel glycosylinositol phosphorylceramides with core Man16Ins linkage. MS Toledo SB Levery J Glushka AH Straus HK Takahashi, Biochem Biophys Res Commun 2001 280 19 24 10.1006/bbrc.2000.4091 11162471
23. 212Ins motif. MS Toledo SB Levery AH Straus HK Takahashi, FEBS Letters 2001 493 50 56 10.1016/S0014-5793(01)02275-X 11278004
24. Characterization of monoclonal antibody MEST-2 specific to glucosylceramide of fungi and plants. MS Toledo E Suzuki SB Levery AH Straus HK Takahashi, Glycobiology 2001 11 105 112 10.1093/glycob/11.2.105 11287397
25. Chemistry and functional moiety of a fruiting-inducing cerebroside in Schizophyllum commune. G Kawai Y Ikeda, Biochim Biophys Acta 1983 754 243 248
26. Structure of biologically active and inactive cerebrosides prepared from Schizophyllum commune. G Kawai Y Ikeda, J Lipid Res 1985 26 338 343 4039347
27. Molecular species of cerebrosides in fruiting bodies of Lentinus edodes and their biological activity. G Kawai, Biochim Biophys Acta 1989 1001 185 190 2917142
28. Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth. ML Rodrigues L Travassos KR Miranda AJ Franzen S Rozental W Souza CS Alviano E Barreto-Bergter, Infec Immun 2000 68 7049 7060 10.1128/IAI.68.12.7049-7060.2000 (Pubitemid 32463419)
29. Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast. M Bagnat S Keränen A Shevchenko A Shevchenko K Simons, Proc Natl Acad Sci USA 2000 97 3254 3259 10.1073/pnas.060034697 10716729
30. Lipid rafts in Cryptococcus neoformans concentrate the virulence determinants phospholipase B1 and Cu/Zn superoxide dismutase. AR Siafakas LC Wright TC Sorrell JT Djordjevic, Eukaryot Cell 2006 5 488 498 10.1128/EC.5.3.488-498.2006 16524904
31. Up-regulation of genes encoding glycosylphosphatidylinositol (GPI)-attached proteins in response to cell wall damage caused by disruption of FKS1 in Saccharomyces cerevisiae. H Terashima N Yabuki M Arisawa K Hamada K Kitada, Mol Gen Genet 2000 264 64 74 10.1007/s004380000285 11016834
32. Structural characterization of a new galactofuranose-containing glycolipid antigen of Paracoccidioides brasiliensis. SB Levery MS Toledo E Suzuki ME Salyan S Hakomori AH Straus HK Takahashi, Biochem Biophys Res Commun 1996 222 639 645 10.1006/bbrc.1996.0796 8670257
33. Characterization of cerebrosides from the thermally dimorphic mycopathogen Histoplasma capsulatum : expression of 2-hydroxy fatty N-acyl (E)-Delta(3)-unsaturation correlates with the yeast-mycelium phase transition. MS Toledo SB Levery E Suzuki AH Straus HK Takahashi, Glycobiology 2001 11 113 124 10.1093/glycob/11.2.113 11287398
34. Gangliosides of human, bovine, and rabbit plasma. RK Yu RW Ledeen, J Lipid Res 1972 13 680 686 5075512
35. Stage-specific glycosphingolipids from amastigote forms of Leishmania (L.) amazonensis. Immunogenicity and role in parasite binding and invasion of macrophages. AH Straus SB Levery MG Jasiulionis ME Salyan SJ Steele LR Travassos S Hakomori HK Takahashi, J Biol Chem 1993 268 13723 13730 8514804
36. Glycosphingolipid antigens from Leishmania (L.) amazonensis amastigotes. Binding of anti-glycosphingolipid monoclonal antibodies in vitro and in vivo. AH Straus VB Valero CM Takizawa SB Levery MS Toledo E Suzuki ME Salyan S Hakomori CL Barbieri HK Takahashi, Braz J Med Biol Res 1997 30 395 399 10.1590/S0100-879X1997000300014 9246238
37. ST-1 a monoclonal antibody specific for intact heparin. AH Straus LR Travassos HK Takahashi, Anal Biochem 1992 201 1 8 10.1016/0003-2697(92)90167-6 1377883
38. 125I-labeled toxin to thin-layer chromatography. JL Magnani DF Smith V Ginsburg, Anal Biochem 1980 109 399 402 10.1016/0003-2697(80)90667-3 7224165
39. Identification of GM3 as a marker of therapy-resistant periradicular lesions. ML Zuolo MS Toledo HE Nogueira AH Straus HK Takahashi, J Endodon 2001 27 107 109 10.1097/00004770-200102000-00012
40. Immunoglobulin G3 monoclonal antibody directed to Tn antigen (tumor-associated alpha-N-acetylgalactosaminyl epitope) that does not cross-react with blood group A antigen. HK Takahashi R Metoki S Hakomori, Cancer Res 1988 48 4361 4367 3390832
41. Antimicrobial effect of farnesol, a Candida albicans quorum sensing molecule, on Paracoccidioides brasiliensis growth and morphogenesis. LS Derengowski C De-Souza-Silva SV Braz TM Mello-De-Sousa SN Bo CM Kyaw I Silva-Pereira, Ann Clin Microbiol Antimicrob 2009 8 13 10.1186/1476-0711-8-13 19402910